Mandate

Vinge advises Industrifonden in connection with financing

March 02, 2020 Intellectual Property

Vinge has advised Industrifonden in connection with Industrifonden leading a financing round in the amount of EUR 6 million in Elypta, a Swedish company which works with cancer diagnostics.

Vinge’s team primarily consisted of Johan Larsson, Kristina Ekberg, Stojan Arnerstål and Arvid Axelryd.

Related

Vinge has advised Orexo in connection with the divestment of the US rights to Zubsolv

Vinge has advised Orexo in relation to Swedish law in connection with the divestment of the US rights to Zubsolv to Dexcel Pharma USA.
January 14, 2026

Vinge advises Revivo Group on acquisition of Haapanen

Revivo Group, a comprehensive provider of qualified surface treatment services, has acquired Haapanen, a well-established Finnish specialist company.
January 14, 2026

Vinge advises Morrow Bank in connection with cross-border merger and list change from Oslo Børs to Nasdaq Stockholm

Vinge has advised Morrow Bank in connection with its reverse cross-border merger, whereby Morrow Bank AB is taking over Morrow Bank ASA. The Norwegian bank was previously listed on the Oslo Stock Exchange which was today transferred to Nasdaq Stockholm. Vinge has previously assisted Morrow Bank in obtaining a Swedish banking licence.
January 12, 2026